|
1) McCay CM, Crowell MF. Prolonging the life span. The Scientific Monthly. 1934; 39: 405-14
|
|
|
|
|
2) Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in Rhesus monkeys. Science. 2009; 325: 201-4
|
|
|
|
|
3) Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science. 2010; 328: 321-6
|
|
|
|
|
|
4) Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000; 289: 2126-8
|
|
|
|
|
|
5) Liang F, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endocrinol. 2009; 5: 367-73
|
|
|
|
|
|
6) McKiernan SH, Tuen VC, Baldwin K, et al. Adult-onset calorie restriction delays the accumulation of mitochondrial enzyme abnormalities in aging rat kidney tubular epithelial cells. Am J Physiol Renal Physiol. 2007; 292: F1751-60
|
|
|
|
|
|
7) Cherry, Engelman RW, Wang BY, et al. Calorie restriction delays the crescentic glomerulonephritis of SCG/Kj mice. Proc Soc Exp Biol Med. 1998; 218: 218-22
|
|
|
|
|
|
8) He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010: 120: 1056-68
|
|
|
|
|
|
9) Kume S, Haneda M, Kanasaki K, et al. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med. 2006; 40: 2175-82
|
|
|
|
|
|
10) Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004; 305: 390-2
|
|
|
|
|
|
11) Tikoo K, Singh K, Kabra D, et al. Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic Res. 2008; 42: 397-404
|
|
|
|
|
|
12) Kume S, Uzu T, Horiike K, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest. 2010; 120: 1043-55
|
|
|
|
|
|
13) Hasegawa K, Wakino S, Yoshioka K, et al. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun. 2008; 372: 51-6
|
|
|
|
|
|
14) Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006; 17: 17-25
|
|
|
|
|
|
15) Dioum EM, Chen R, Alexander MS, et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science. 2009; 324: 1289-93
|
|
|
|
|
|
16) Hasegawa K, Wakino S, Yoshioka K, et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem. 2010; 285: 13045-56
|
|
|
|
|
|
17) Li J, Qu X, Ricardo SD, et al. Resveratrol inhibits renal fibrosis in the obstructed kidney. Potential role in deacetylation of Smad3. Am J Pathol. 2010; in Press
|
|
|
|
|
|
18) Uzu T, Kimura G, Yamauchi A, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006; 24: 1627-32
|
|
|
|
|
|
19) Miyazaki R, Ichiki T, Hashimoto T, et al. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008; 28: 1263-9
|
|
|
|
|
|
20) Mattagajasingh I, Kim CS, Naqvi A, et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 2007; 104: 14855-60
|
|
|
|
|
|
21) Zhang D, Li S, Cruz P, et al. Sirtuin 1 functionally and physically interacts with disruptor of telomeric silencing-1 to regulate alpha-ENaC transcription in collecting duct. J Biol Chem. 2009; 284: 20917-26
|
|
|
|
|
|
22) Kume S, Haneda M, Kanasaki K, et al. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem. 2007; 282: 151-8
|
|
|
|
|
|
23) Lieberthal W, Levine JS. The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol. 2009; 20: 2493-502
|
|
|
|
|
|
24) Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008; 118: 1645-56
|
|
|
|
|
|
25) Kume S, Uzu T, Araki S, et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol. 2007; 18: 2715-23
|
|
|
|
|
|
26) Hallows KR, Mount PF, Pastor-Soler NM. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol. 2010; in press
|
|
|
|
|
|
27) Ghosh HS, McBurney M, Robbins PD. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One. 2010; 5: e9199]
|
|
|
|
|
|
28) Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca2＋ and AMPK/SIRT1. Nature. 2010; 464: 1313-9
|
|
|
|
|
|
29) Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD＋ metabolism and SIRT1 activity. Nature. 2009; 458: 1056-60
|
|
|
|
|
|
30) Gwinn DM, Shackelford DB, Egan DF. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008; 30: 214-26
|
|
|
|
|